KaloBios Pharmaceuticals, Inc. Announces Management Changes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Martin Shkreli Says His Twitter Account was Hacked
December 21, 2015 11:17 AM ESTMartin Shkreli said he has regained control of his Twitter account after being hacked.
The former Turing Pharmaceuticals and KaloBios Pharma (NASDAQ: KBIO) CEO was arrested last week for securities fraud related to past dealings with his hedge fund and former company... More
KaloBios Pharma (KBIO) Trading Halt Remains in Effect Despite CEO Firing Update
December 21, 2015 10:07 AM ESTDespite today's firing of CEO, Martin Shkreli, KaloBios Pharma (NASDAQ: KBIO) shares remain halted on the NASDAQ exchange with a T12 halt... More
